A clinical update on the significance of the gut microbiota in systemic autoimmunity

Journal of Autoimmunity

Volumn 74, Issue , 2016, Pages 85-93

  Rosser, Elizabeth C ^a   Mauri, Claudia ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Autoimmunity; Dysbiosis; Gut microbiota; Inflammation

Indexed keywords

DNA;

AGE; AUTOIMMUNITY; DIET; DNA SEQUENCE; ENVIRONMENTAL FACTOR; HUMAN; IMMUNE SYSTEM; IMMUNOGENETICS; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; AUTOIMMUNE DISEASE; CYTOLOGY; DISEASE MODEL; DYSBIOSIS; IMMUNOLOGY; METABOLISM; RISK FACTOR;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTORS;

EID: 84992597804     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2016.06.009     Document Type: Review

References (78)

1. [1] Rahman, A., Isenberg, D.A., Systemic lupus erythematosus. N. Engl. J. Med. 358:9 (2008), 929–939, 10.1056/NEJMra071297.
2. [2] Hevia, A., Milani, C., Lopez, P., Cuervo, A., Arboleya, S., Duranti, S., Turroni, F., Gonzalez, S., Suarez, A., Gueimonde, M., Ventura, M., Sanchez, B., Margolles, A., Intestinal dysbiosis associated with systemic lupus erythematosus. MBio, 5(5), 2014, 10.1128/mBio.01548-14 e01548–01514.
3. [3] Rojo, D., Hevia, A., Bargiela, R., Lopez, P., Cuervo, A., Gonzalez, S., Suarez, A., Sanchez, B., Martinez-Martinez, M., Milani, C., Ventura, M., Barbas, C., Moya, A., Margolles, A., Ferrer, M., Ranking the impact of human health disorders on gut metabolism: systemic lupus erythematosus and obesity as study cases. Sci. Rep., 5, 2015, 8310, 10.1038/srep08310.
4. [4] Honda, K., Littman, D.R., The microbiome in infectious disease and inflammation. Annu. Rev. Immunol. 30 (2012), 759–795, 10.1146/annurev-immunol-020711-074937.
5. [5] Hooper, L.V., Macpherson, A.J., Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 10:3 (2010), 159–169, 10.1038/nri2710.
6. [6] Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., Mende, D.R., Li, J., Xu, J., Li, S., Li, D., Cao, J., Wang, B., Liang, H., Zheng, H., Xie, Y., Tap, J., Lepage, P., Bertalan, M., Batto, J.M., Hansen, T., Le Paslier, D., Linneberg, A., Nielsen, H.B., Pelletier, E., Renault, P., Sicheritz-Ponten, T., Turner, K., Zhu, H., Yu, C., Jian, M., Zhou, Y., Li, Y., Zhang, X., Qin, N., Yang, H., Wang, J., Brunak, S., Dore, J., Guarner, F., Kristiansen, K., Pedersen, O., Parkhill, J., Weissenbach, J., Bork, P., Ehrlich, S.D., A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:7285 (2010), 59–65, 10.1038/nature08821.
7. [7] Weisburg, W.G., Barns, S.M., Pelletier, D.A., Lane, D.J., 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173:2 (1991), 697–703.
8. [8] Peterson, J., Garges, S., Giovanni, M., McInnes, P., Wang, L., Schloss, J.A., Bonazzi, V., McEwen, J.E., Wetterstrand, K.A., Deal, C., Baker, C.C., Di Francesco, V., Howcroft, T.K., Karp, R.W., Lunsford, R.D., Wellington, C.R., Belachew, T., Wright, M., Giblin, C., David, H., Mills, M., Salomon, R., Mullins, C., Akolkar, B., Begg, L., Davis, C., Grandison, L., Humble, M., Khalsa, J., Little, A.R., Peavy, H., Pontzer, C., Portnoy, M., Sayre, M.H., Starke-Reed, P., Zakhari, S., Read, J., Watson, B., Guyer, M., The NIH human microbiome project. Genome Res. 19:12 (2009), 2317–2323, 10.1101/gr.096651.109.
9. [9] Zoetendal, E.G., Rajilic-Stojanovic, M., de Vos, W.M., High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57:11 (2008), 1605–1615, 10.1136/gut.2007.133603.
10. [10] Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., Relman, D.A., Diversity of the human intestinal microbial flora. Science 308:5728 (2005), 1635–1638, 10.1126/science.1110591.
11. [11] Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., Fernandes, G.R., Tap, J., Bruls, T., Batto, J.M., Bertalan, M., Borruel, N., Casellas, F., Fernandez, L., Gautier, L., Hansen, T., Hattori, M., Hayashi, T., Kleerebezem, M., Kurokawa, K., Leclerc, M., Levenez, F., Manichanh, C., Nielsen, H.B., Nielsen, T., Pons, N., Poulain, J., Qin, J., Sicheritz-Ponten, T., Tims, S., Torrents, D., Ugarte, E., Zoetendal, E.G., Wang, J., Guarner, F., Pedersen, O., de Vos, W.M., Brunak, S., Dore, J., Antolin, M., Artiguenave, F., Blottiere, H.M., Almeida, M., Brechot, C., Cara, C., Chervaux, C., Cultrone, A., Delorme, C., Denariaz, G., Dervyn, R., Foerstner, K.U., Friss, C., van de Guchte, M., Guedon, E., Haimet, F., Huber, W., van Hylckama-Vlieg, J., Jamet, A., Juste, C., Kaci, G., Knol, J., Lakhdari, O., Layec, S., Le Roux, K., Maguin, E., Merieux, A., Melo Minardi, R., M'Rini, C., Muller, J., Oozeer, R., Parkhill, J., Renault, P., Rescigno, M., Sanchez, N., Sunagawa, S., Torrejon, A., Turner, K., Vandemeulebrouck, G., Varela, E., Winogradsky, Y., Zeller, G., Weissenbach, J., Ehrlich, S.D., Bork, P., Enterotypes of the human gut microbiome. Nature 473:7346 (2011), 174–180, 10.1038/nature09944.
12. [12] Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., Diversity, stability and resilience of the human gut microbiota. Nature 489:7415 (2012), 220–230, 10.1038/nature11550.
13. [13] Arrieta, M.C., Stiemsma, L.T., Amenyogbe, N., Brown, E.M., Finlay, B., The intestinal microbiome in early life: health and disease. Front. Immunol., 5, 2014, 427, 10.3389/fimmu.2014.00427.
14. [14] Rodriguez, J.M., Murphy, K., Stanton, C., Ross, R.P., Kober, O.I., Juge, N., Avershina, E., Rudi, K., Narbad, A., Jenmalm, M.C., Marchesi, J.R., Collado, M.C., The composition of the gut microbiota throughout life, with an emphasis on early life. Microb. Ecol. Health Dis., 26, 2015, 26050, 10.3402/mehd.v26.26050.
15. [15] Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R.N., Anokhin, A.P., Heath, A.C., Warner, B., Reeder, J., Kuczynski, J., Caporaso, J.G., Lozupone, C.A., Lauber, C., Clemente, J.C., Knights, D., Knight, R., Gordon, J.I., Human gut microbiome viewed across age and geography. Nature 486:7402 (2012), 222–227, 10.1038/nature11053.
16. [16] Gronlund, M.M., Lehtonen, O.P., Eerola, E., Kero, P., Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J. Pediatr. Gastroenterol. Nutr. 28:1 (1999), 19–25.
17. [17] Marques, T.M., Wall, R., Ross, R.P., Fitzgerald, G.F., Ryan, C.A., Stanton, C., Programming infant gut microbiota: influence of dietary and environmental factors. Curr. Opin. Biotechnol. 21:2 (2010), 149–156, 10.1016/j.copbio.2010.03.020.
18. [18] Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M.J., Valles-Colomer, M., Vandeputte, D., Tito, R.Y., Chaffron, S., Rymenans, L., Verspecht, C., De Sutter, L., Lima-Mendez, G., D'Hoe, K., Jonckheere, K., Homola, D., Garcia, R., Tigchelaar, E.F., Eeckhaudt, L., Fu, J., Henckaerts, L., Zhernakova, A., Wijmenga, C., Raes, J., Population-level analysis of gut microbiome variation. Science 352:6285 (2016), 560–564, 10.1126/science.aad3503.
19. [19] Zeissig, S., Blumberg, R.S., Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease. Nat. Immunol. 15:4 (2014), 307–310, 10.1038/ni.2847.
20. [20] Horton, D.B., Scott, F.I., Haynes, K., Putt, M.E., Rose, C.D., Lewis, J.D., Strom, B.L., Antibiotic exposure and juvenile idiopathic arthritis: a case-control study. Pediatrics 136:2 (2015), e333–343, 10.1542/peds.2015-0036.
21. [21] Arvonen, M., Virta, L.J., Pokka, T., Kroger, L., Vahasalo, P., Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections?. J. Rheumatol. 42:3 (2015), 521–526, 10.3899/jrheum.140348.
22. [22] Murri, M., Leiva, I., Gomez-Zumaquero, J.M., Tinahones, F.J., Cardona, F., Soriguer, F., Queipo-Ortuno, M.I., Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med., 11, 2013, 46, 10.1186/1741-7015-11-46.
23. [23] Murk, W., Risnes, K.R., Bracken, M.B., Prenatal or early-life exposure to antibiotics and risk of childhood asthma: a systematic review. Pediatrics 127:6 (2011), 1125–1138, 10.1542/peds.2010-2092.
24. [24] Mariat, D., Firmesse, O., Levenez, F., Guimaraes, V., Sokol, H., Dore, J., Corthier, G., Furet, J.P., The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol., 9, 2009, 123, 10.1186/1471-2180-9-123.
25. [25] Claesson, M.J., Jeffery, I.B., Conde, S., Power, S.E., O'Connor, E.M., Cusack, S., Harris, H.M., Coakley, M., Lakshminarayanan, B., O'Sullivan, O., Fitzgerald, G.F., Deane, J., O'Connor, M., Harnedy, N., O'Connor, K., O'Mahony, D., van Sinderen, D., Wallace, M., Brennan, L., Stanton, C., Marchesi, J.R., Fitzgerald, A.P., Shanahan, F., Hill, C., Ross, R.P., O'Toole, P.W., Gut microbiota composition correlates with diet and health in the elderly. Nature 488:7410 (2012), 178–184, 10.1038/nature11319.
26. [26] Dicksved, J., Halfvarson, J., Rosenquist, M., Jarnerot, G., Tysk, C., Apajalahti, J., Engstrand, L., Jansson, J.K., Molecular analysis of the gut microbiota of identical twins with Crohn's disease. Isme J. 2:7 (2008), 716–727, 10.1038/ismej.2008.37.
27. [27] Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., Egholm, M., Henrissat, B., Heath, A.C., Knight, R., Gordon, J.I., A core gut microbiome in obese and lean twins. Nature 457:7228 (2009), 480–484, 10.1038/nature07540.
28. [28] Yurkovetskiy, L., Burrows, M., Khan, A.A., Graham, L., Volchkov, P., Becker, L., Antonopoulos, D., Umesaki, Y., Chervonsky, A.V., Gender bias in autoimmunity is influenced by microbiota. Immunity 39:2 (2013), 400–412, 10.1016/j.immuni.2013.08.013.
29. [29] Stoll, M.L., Kumar, R., Morrow, C.D., Lefkowitz, E.J., Cui, X., Genin, A., Cron, R.Q., Elson, C.O., Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res. Ther., 16(6), 2014, 486, 10.1186/s13075-014-0486-0.
30. [30] Haro, C., Rangel-Zuniga, O.A., Alcala-Diaz, J.F., Gomez-Delgado, F., Perez-Martinez, P., Delgado-Lista, J., Quintana-Navarro, G.M., Landa, B.B., Navas-Cortes, J.A., Tena-Sempere, M., Clemente, J.C., Lopez-Miranda, J., Perez-Jimenez, F., Camargo, A., Intestinal microbiota is influenced by gender and body mass index. PLoS One, 11(5), 2016, e0154090, 10.1371/journal.pone.0154090.
31. [31] Gomez, A., Luckey, D., Yeoman, C.J., Marietta, E.V., Berg Miller, M.E., Murray, J.A., White, B.A., Taneja, V., Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One, 7(4), 2012, e36095, 10.1371/journal.pone.0036095.
32. [32] Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., Bewtra, M., Knights, D., Walters, W.A., Knight, R., Sinha, R., Gilroy, E., Gupta, K., Baldassano, R., Nessel, L., Li, H., Bushman, F.D., Lewis, J.D., Linking long-term dietary patterns with gut microbial enterotypes. Science 334:6052 (2011), 105–108, 10.1126/science.1208344.
33. [33] Walker, A.W., Ince, J., Duncan, S.H., Webster, L.M., Holtrop, G., Ze, X., Brown, D., Stares, M.D., Scott, P., Bergerat, A., Louis, P., McIntosh, F., Johnstone, A.M., Lobley, G.E., Parkhill, J., Flint, H.J., Dominant and diet-responsive groups of bacteria within the human colonic microbiota. Isme J. 5:2 (2011), 220–230, 10.1038/ismej.2010.118.
34. [34] Russell, W.R., Gratz, S.W., Duncan, S.H., Holtrop, G., Ince, J., Scobbie, L., Duncan, G., Johnstone, A.M., Lobley, G.E., Wallace, R.J., Duthie, G.G., Flint, H.J., High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am. J. Clin. Nutr. 93:5 (2011), 1062–1072, 10.3945/ajcn.110.002188.
35. [35] Nicholson, J.K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., Pettersson, S., Host-gut microbiota metabolic interactions. Science 336:6086 (2012), 1262–1267, 10.1126/science.1223813.
36. [36] Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., Brummer, R.J., Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27:2 (2008), 104–119, 10.1111/j.1365-2036.2007.03562.x.
37. [37] Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N.N., Murakami, S., Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., Clarke, J.M., Topping, D.L., Tomita, M., Hori, S., Ohara, O., Morita, T., Koseki, H., Kikuchi, J., Honda, K., Hase, K., Ohno, H., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:7480 (2013), 446–450, 10.1038/nature12721.
38. [38] Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J.R., Pfeffer, K., Coffer, P.J., Rudensky, A.Y., Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504:7480 (2013), 451–455, 10.1038/nature12726.
39. [39] Cerf-Bensussan, N., Gaboriau-Routhiau, V., The immune system and the gut microbiota: friends or foes?. Nat. Rev. Immunol. 10:10 (2010), 735–744, 10.1038/nri2850.
40. [40] Bouskra, D., Brezillon, C., Berard, M., Werts, C., Varona, R., Boneca, I.G., Eberl, G., Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456:7221 (2008), 507–510, 10.1038/nature07450.
41. [41] Macpherson, A.J., Harris, N.L., Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4:6 (2004), 478–485, 10.1038/nri1373.
42. [42] Crabbe, P.A., Bazin, H., Eyssen, H., Heremans, J.F., Normal microbial flora as a major stimulus for proliferation of plasma cells synthesizing iga in gut – germ-free intestinal tract. Int. Arch. Aller a Imm., 34(4), 1968, 362.
43. [43] Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C., Santee, C.A., Lynch, S.V., Tanoue, T., Imaoka, A., Itoh, K., Takeda, K., Umesaki, Y., Honda, K., Littman, D.R., Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:3 (2009), 485–498, 10.1016/j.cell.2009.09.033.
44. [44] Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., Taniguchi, T., Takeda, K., Hori, S., Ivanov, I.I., Umesaki, Y., Itoh, K., Honda, K., Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:6015 (2011), 337–341, 10.1126/science.1198469.
45. [45] Hooijkaas, H., Benner, R., Pleasants, J.R., Wostmann, B.S., Isotypes and specificities of immunoglobulins produced by germ-free mice fed chemically defined ultrafiltered “antigen-free” diet. Eur. J. Immunol. 14:12 (1984), 1127–1130, 10.1002/eji.1830141212.
46. [46] Bauer, H., Horowitz, R.E., Levenson, S.M., Popper, H., The response of the lymphatic tissue to the microbial flora. Studies on germfree mice. Am. J. Pathol. 42 (1963), 471–483.
47. [47] Abt, M.C., Osborne, L.C., Monticelli, L.A., Doering, T.A., Alenghat, T., Sonnenberg, G.F., Paley, M.A., Antenus, M., Williams, K.L., Erikson, J., Wherry, E.J., Artis, D., Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37:1 (2012), 158–170, 10.1016/j.immuni.2012.04.011.
48. [48] Rosser, E.C., Oleinika, K., Tonon, S., Doyle, R., Bosma, A., Carter, N.A., Harris, K.A., Jones, S.A., Klein, N., Mauri, C., Regulatory B cells are induced by gut microbiota-driven interleukin-1beta and interleukin-6 production. Nat. Med. 20:11 (2014), 1334–1339, 10.1038/nm.3680.
49. [49] Wu, H.J., Ivanov, I.I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D.R., Benoist, C., Mathis, D., Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32:6 (2010), 815–827, 10.1016/j.immuni.2010.06.001.
50. [50] Lee, Y.K., Menezes, J.S., Umesaki, Y., Mazmanian, S.K., Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 108:Suppl. 1 (2011), 4615–4622, 10.1073/pnas.1000082107.
51. [51] Van Praet, J.T., Donovan, E., Vanassche, I., Drennan, M.B., Windels, F., Dendooven, A., Allais, L., Cuvelier, C.A., van de Loo, F., Norris, P.S., Kruglov, A.A., Nedospasov, S.A., Rabot, S., Tito, R., Raes, J., Gaboriau-Routhiau, V., Cerf-Bensussan, N., Van de Wiele, T., Eberl, G., Ware, C.F., Elewaut, D., Commensal microbiota influence systemic autoimmune responses. Embo J. 34:4 (2015), 466–474, 10.15252/embj.201489966.
52. [52] Berer, K., Mues, M., Koutrolos, M., Rasbi, Z.A., Boziki, M., Johner, C., Wekerle, H., Krishnamoorthy, G., Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479:7374 (2011), 538–541, 10.1038/nature10554.
53. [53] Maldonado, M.A., Kakkanaiah, V., MacDonald, G.C., Chen, F., Reap, E.A., Balish, E., Farkas, W.R., Jennette, J.C., Madaio, M.P., Kotzin, B.L., Cohen, P.L., Eisenberg, R.A., The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J. Immunol. 162:11 (1999), 6322–6330.
54. [54] East, J., Branca, M., Autoimmune reactions and malignant changes in germ-free New Zealand Black mice. Clin. Exp. Immunol. 4:6 (1969), 621–635.
55. [55] Mizutani, A., Shaheen, V.M., Yoshida, H., Akaogi, J., Kuroda, Y., Nacionales, D.C., Yamasaki, Y., Hirakata, M., Ono, N., Reeves, W.H., Satoh, M., Pristane-induced autoimmunity in germ-free mice. Clin. Immunol. 114:2 (2005), 110–118, 10.1016/j.clim.2004.09.010.
56. [56] Zhang, H., Liao, X., Sparks, J.B., Luo, X.M., Dynamics of gut microbiota in autoimmune lupus. Appl. Environ. Microbiol. 80:24 (2014), 7551–7560, 10.1128/AEM.02676-14.
57. [57] Gaudreau, M.C., Johnson, B.M., Gudi, R., Al-Gadban, M.M., Vasu, C., Gender bias in lupus: does immune response initiated in the gut mucosa have a role?. Clin. Exp. Immunol. 180:3 (2015), 393–407, 10.1111/cei.12587.
58. [58] Markle, J.G., Frank, D.N., Mortin-Toth, S., Robertson, C.E., Feazel, L.M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K.D., Macpherson, A.J., Danska, J.S., Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339:6123 (2013), 1084–1088, 10.1126/science.1233521.
59. [59] Johnson, B.M., Gaudreau, M.C., Al-Gadban, M.M., Gudi, R., Vasu, C., Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice. Clin. Exp. Immunol. 181:2 (2015), 323–337, 10.1111/cei.12609.
60. [60] Scher, J.U., Sczesnak, A., Longman, R.S., Segata, N., Ubeda, C., Bielski, C., Rostron, T., Cerundolo, V., Pamer, E.G., Abramson, S.B., Huttenhower, C., Littman, D.R., Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife, 2, 2013, e01202, 10.7554/eLife.01202.
61. [61] Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., Lan, Z., Chen, B., Zhong, H., Xie, H., Jie, Z., Chen, W., Tang, S., Xu, X., Wang, X., Cai, X., Liu, S., Xia, Y., Qiao, X., Al-Aama, J.Y., Chen, H., Wang, L., Wu, Q.J., Zhang, F., Zheng, W., Zhang, M., Luo, G., Xue, W., Xiao, L., Yin, Y., Yang, H., Wang, J., Kristiansen, K., Liu, L., Li, T., Huang, Q., The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21:8 (2015), 895–905, 10.1038/nm.3914.
62. [62] Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.W., Morita, H., Hattori, M., Yamamura, T., Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS One, 10(9), 2015, e0137429, 10.1371/journal.pone.0137429.
63. [63] Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., Roca, J., Dore, J., Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55:2 (2006), 205–211, 10.1136/gut.2005.073817.
64. [64] Lopez, P., de Paz, B., Rodriguez-Carrio, J., Hevia, A., Sanchez, B., Margolles, A., Suarez, A., Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci. Rep., 6, 2016, 24072, 10.1038/srep24072.
65. [65] Banchereau, J., Pascual, V., Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25:3 (2006), 383–392, 10.1016/j.immuni.2006.08.010.
66. [66] Menon, M., Blair, P.A., Isenberg, D.A., Mauri, C., A regulatory feedback between plasmacytoid dendritic cells and regulatory b cells is aberrant in systemic lupus erythematosus. Immunity 44:3 (2016), 683–697, 10.1016/j.immuni.2016.02.012.
67. [67] Graham, D.Y., Lew, G.M., Klein, P.D., Evans, D.G., Evans, D.J. Jr., Saeed, Z.A., Malaty, H.M., Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann. Intern Med. 116:9 (1992), 705–708.
68. [68] Langevitz, P., Livneh, A., Bank, I., Pras, M., Benefits and risks of minocycline in rheumatoid arthritis. Drug Saf. 22:5 (2000), 405–414.
69. [69] Golub, L.M., Ramamurthy, N.S., McNamara, T.F., Greenwald, R.A., Rifkin, B.R., Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit. Rev. Oral Biol. Med. 2:3 (1991), 297–321.
70. [70] Marzo-Ortega, H., Misbah, S., Emery, P., Minocycline induced autoimmune disease in rheumatoid arthritis: a missed diagnosis?. J. Rheumatol. 28:2 (2001), 377–378.
71. [71] Golstein, P.E., Deviere, J., Cremer, M., Acute hepatitis and drug-related lupus induced by minocycline treatment. Am. J. Gastroenterol. 92:1 (1997), 143–146.
72. [72] Borody, T.J., Warren, E.F., Leis, S., Surace, R., Ashman, O., Treatment of ulcerative colitis using fecal bacteriotherapy. J. Clin. Gastroenterol. 37:1 (2003), 42–47.
73. [73] Borody, T., Leis, S., Campbell, J., Torres, M., Nowak, A., Fecal microbiota transplantation (FMT) in multiple sclerosis (MS). Am. J. Gastroenterol., 106, 2011 S352–S352.
74. [74] Borody, T., Rosen, D., Torres, M., Campbell, J., Nowak, A., Myoclonus-dystonia affected by GI microbiota?. Am. J. Gastroenterol. 106 (2011), S351–S352.
75. [75] Matsuzaki, T., Yamazaki, R., Hashimoto, S., Yokokura, T., Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr. J. 44:3 (1997), 357–365.
76. [76] Warden, C.C., The toxemic factor in rheumatoid arthritis. Cal. State J. Med. 7:8 (1909), 299–301.
77. [77] Slavin, J., Fiber and prebiotics: mechanisms and health benefits. Nutrients 5:4 (2013), 1417–1435, 10.3390/nu5041417.
78. [78] Chen, C.C., Walker, W.A., Probiotics and prebiotics: role in clinical disease states. Adv. Pediatr. 52 (2005), 77–113.